Perspective Therapeutics: GuRu Wireless Unveils Game-Changing Wireless Power for Unmanned Aerial Systems
- GuRu Wireless's long-range wireless energy transfer enables unmanned aerial systems to fly indefinitely without battery replacements.
- The technology enhances military, surveillance, and public safety capabilities, addressing critical operational challenges.
- GuRu Wireless focuses on innovative solutions to improve drone reliability and performance in defense and civilian sectors.
Innovative Wireless Energy Transfer Technology Poised to Revolutionize Unmanned Aerial Systems
GuRu Wireless, Inc. presents a groundbreaking advancement in adaptive, long-range wireless energy transfer technology that has the potential to transform the landscape of unmanned aerial systems (UAS). Demonstrated at the Army Aviation Unmanned Aircraft Systems & Launched Effects Industry Day on February 10, 2025, in Fort Novosel, Alabama, GuRu’s technology enables small unmanned aerial systems (sUAS) to fly indefinitely without the need for battery replacements or recharging. This innovative approach is powered by a scalable, fully synchronous wireless power transfer platform operating at 24GHz, showcasing a significant development in the quest for persistent flight capabilities.
The implications of GuRu Wireless’s technology extend far beyond commercial applications, targeting critical needs in national security and defense sectors. CEO Narbeh Derhacobian underscores the importance of this advancement in addressing long-standing challenges associated with wireless energy transfer, positioning the company as a key player in enhancing operational efficiencies for military and defense applications. The capacity for sUAS to maintain flight without interruption not only augments their utility in surveillance and reconnaissance missions but also opens doors for their use in public safety initiatives, providing continuous support in emergency situations.
GuRu Wireless, established in 2017 by a team from Caltech, has consistently focused on innovation, conducting multiple proof-of-concept projects across diverse sectors. In 2024, the company shifted its attention toward developing comprehensive end-to-end solutions that enhance the flight and intelligence, surveillance, and reconnaissance (ISR) capabilities of sUAS. This strategic direction marks a transformative shift, enabling drones to perform critical missions with extended operational duration and reliability. The proprietary Long-range Wireless Power Beaming (LRWPB) technology not only represents a leap forward in drone capabilities but also aligns with the increasing demand for advanced UAS in both defense and civilian applications.
In addition to its recent demonstration, GuRu Wireless continues to attract strategic investment from leading deep technology firms, reinforcing its commitment to innovation in the wireless energy transfer space. The company’s technology is not only a significant asset for military applications but also holds promise for various industries looking to leverage drone capabilities. Interested parties can view the demonstration online, providing valuable insights into the potential applications and benefits of GuRu’s technology across multiple fields.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

